Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Adjusted Operating Profit — Non-GAAP by Quarter
Adjusted Operating Profit — Non-GAAP ($M)
Danaher Adjusted Operating Profit — Non-GAAP: $1,900M in Q3 2026, up 12.6% from a year earlier.
Where the Q3 2026 figure comes from
Source: Danaher IR — nongaap_2026Q3 ↗
Excludes amortization of M&A intangible assets, restructuring/transaction costs, and fair value adjustments to acquired inventory.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Adjusted Operating Profit — Non-GAAP ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 1,900 | +12.6% | Danaher IR — nongaap_2026Q3 ↗ |
| Q2 2026 | Jun 30, 2026 | 1,698 | +4.9% | Danaher IR — nongaap_2026Q2 ↗ |
| Q1 2026 | Mar 31, 2026 | 1,795 | +5.7% | Danaher IR — nongaap_2026Q1 ↗ |
| Q4 2025 | Dec 31, 2025 | 1,934 | +0.1% | Danaher IR — nongaap_2025Q4 ↗ |
| Q3 2025 | Sep 30, 2025 | 1,688 | +5.9% | Danaher IR — nongaap_2026Q3 ↗ |
| Q2 2025 | Jun 30, 2025 | 1,618 | +3.1% | Danaher IR — nongaap_2026Q2 ↗ |
| Q1 2025 | Mar 31, 2025 | 1,699 | -2.6% | Danaher IR — nongaap_2026Q1 ↗ |
| Q4 2024 | Dec 31, 2024 | 1,932 | +5.2% | Danaher IR — nongaap_2025Q4 ↗ |
| Q3 2024 | Sep 30, 2024 | 1,594 | +2.7% | Danaher IR — nongaap_2025Q3 ↗ |
| Q2 2024 | Jun 30, 2024 | 1,570 | -0.4% | Danaher IR — nongaap_2025Q2 ↗ |
| Q1 2024 | Mar 31, 2024 | 1,744 | -7.7% | Danaher IR — nongaap_2025Q1 ↗ |
| Q4 2023 | Dec 31, 2023 | 1,837 | -21.8% | Danaher IR — nongaap_2024Q4 ↗ |
| Q3 2023 | Sep 30, 2023 | 1,552 | -24.9% | Danaher IR — nongaap_2024Q3 ↗ |
| Q2 2023 | Jun 30, 2023 | 1,577 | -29.9% | Danaher IR — nongaap_2024Q2 ↗ |
| Q1 2023 | Mar 31, 2023 | 1,889 | -19.4% | Danaher IR — nongaap_ex_veralto ↗ |
| Q4 2022 | Dec 31, 2022 | 2,349 | – | Danaher IR — nongaap_ex_veralto ↗ |
| Q3 2022 | Sep 30, 2022 | 2,067 | – | Danaher IR — nongaap_ex_veralto ↗ |
| Q2 2022 | Jun 30, 2022 | 2,251 | – | Danaher IR — nongaap_ex_veralto ↗ |
| Q1 2022 | Mar 31, 2022 | 2,345 | – | Danaher IR — nongaap_ex_veralto ↗ |
Breakdown
What makes up adjusted Operating Profit — Non-GAAP
- Biotechnology — Adjusted OP756 · Q3 2026
- Life Sciences — Adjusted OP404 · Q3 2026
- Diagnostics — Adjusted OP831 · Q3 2026
- Other / Corporate Unallocated Adjusted Expense-91 · Q3 2026
- Adjusted Operating Profit Margin — Non-GAAP29.0% · Q3 2026
- Biotechnology — Adjusted OP Margin41.8% · Q3 2026
- Life Sciences — Adjusted OP Margin21.7% · Q3 2026
- Diagnostics — Adjusted OP Margin28.8% · Q3 2026
- GAAP Operating Margin19.0% · Q3 2026
- Biotechnology — Reported GAAP Operating Margin26.4% · Q3 2026
- Life Sciences — Reported GAAP Operating Margin13.9% · Q3 2026
- Diagnostics — Reported GAAP Operating Margin21.3% · Q3 2026
- Core Operating Margin Change (percentage points)1.7% · Q3 2026
- Biotechnology — YoY Core Operating Margin Change (percentage points)4.9% · Q3 2026
- Life Sciences — YoY Core Operating Margin Change (percentage points)1.2% · Q3 2026
- Diagnostics — YoY Core Operating Margin Change (percentage points)0.3% · Q3 2026
Cite this data
StockData. (2026). Danaher Adjusted Operating Profit — Non-GAAP ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/adj-op-profit-total
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.